Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
9.20
+0.06 (0.66%)
At close: Feb 13, 2026, 4:00 PM EST
9.38
+0.18 (1.96%)
After-hours: Feb 13, 2026, 7:00 PM EST
Avantor Revenue
In the year 2025, Avantor had annual revenue of $6.55B, down -3.41%. Avantor had revenue of $1.66B in the quarter ending December 31, 2025, a decrease of -1.36%.
Revenue (ttm)
$6.55B
Revenue Growth
-3.41%
P/S Ratio
0.96
Revenue / Employee
$485,348
Employees
13,500
Market Cap
6.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.55B | -231.40M | -3.41% |
| Dec 31, 2024 | 6.78B | -183.60M | -2.64% |
| Dec 31, 2023 | 6.97B | -545.20M | -7.26% |
| Dec 31, 2022 | 7.51B | 126.30M | 1.71% |
| Dec 31, 2021 | 7.39B | 992.50M | 15.52% |
| Dec 31, 2020 | 6.39B | 353.30M | 5.85% |
| Dec 31, 2019 | 6.04B | 176.00M | 3.00% |
| Dec 31, 2018 | 5.86B | 4.62B | 370.12% |
| Dec 31, 2017 | 1.25B | 556.10M | 80.44% |
| Dec 31, 2016 | 691.30M | 54.40M | 8.54% |
| Dec 31, 2015 | 636.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.24B |
| Solventum | 8.40B |
| Bausch + Lomb | 4.98B |
| Align Technology | 4.03B |
| AptarGroup | 3.78B |
| Teleflex | 3.19B |
| Envista Holdings | 2.72B |
| ICU Medical | 2.32B |
AVTR News
- 5 days ago - Avantor Falls To Critical Levels As CEO Signals Investment Year Amid Soft Guidance - Benzinga
- 5 days ago - Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Avantor® Reports Fourth Quarter and Full Year 2025 Results - PRNewsWire
- 4 weeks ago - Longleaf Partners Global Fund 2025 Contributors And Detractors - Seeking Alpha
- 4 weeks ago - Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor - Business Wire
- 5 weeks ago - Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026 - PRNewsWire
- 6 weeks ago - Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire